Skip to main content

Reporter Jan 6 2023

Anti-nausea drug response in children

Jan. 10, 2023—Genetic variation in a metabolic enzyme was not associated with response to the anti-nausea drug odansetron in children, Vanderbilt researchers report.

Read more


Novel lung cancer biomarker

Jan. 9, 2023—Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer.

Read more


Early effects of Huntington disease

Jan. 6, 2023—Impairments in brain executive function happen earlier than motor symptoms in people with the gene mutation that causes Huntington disease, suggesting younger ages and cognitive symptoms be considered for any future clinical trials.

Read more


MicroRNAs linked to lipid damage

Jan. 6, 2023—VUMC researchers have linked microRNAs with systemic lipid peroxidation, a discovery that could point to new therapeutic targets for a variety of diseases.

Read more


VUMC researchers upend dogma about vasopressin production

Jan. 5, 2023—Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney.

Read more


Infectious disease expert Edwards ends storied career

Jan. 5, 2023—Vanderbilt's Kathryn Edwards, MD, internationally recognized for her countless contributions to vaccine evaluation and implementation, public health advocacy, and the mentorship and training of new generations of experts in infectious disease over the past four decades, retired on Dec. 31, 2022.

Read more


VUMC-led COVID-19 clinical trial platform goes international

Jan. 5, 2023—The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally.

Read more


Three elected to the American Pediatric Society

Jan. 5, 2023—Three physicians in the Vanderbilt Department of Pediatrics have been elected to the American Pediatric Society.

Read more


New approach outperforms existing cancer susceptibility models

Jan. 5, 2023—A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.

Read more


VUMC strongly recommends COVID-19 bivalent booster vaccination as new COVID-19 variants appear in our region

Jan. 4, 2023—With the development of new variants of the COVID-19 virus across the U.S. and the world, Vanderbilt University Medical Center recommends getting the bivalent booster vaccination.

Read more


Study shows peer messaging tool can be successfully implemented in the nursing workforce

Jan. 3, 2023—A new study shows that a tool developed at Vanderbilt University Medical Center to address disrespectful workplace behaviors through trained peer-to-peer messaging can be successfully implemented in the nursing workforce with the appropriate support.

Read more


Terhune named Senior Vice President for Educational Affairs

Jan. 3, 2023—Vanderbilt's Kyla Terhune, MD, MBA, Vice President for Educational Affairs and Associate Dean for Graduate Medical Education, has been named Senior Vice President for Educational Affairs.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more